CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 24, 2003--POZEN Inc.
(NASDAQ:POZN), a pharmaceutical company developing therapeutic
advancements in a cost effective manner, today announced it will host
a conference call following the release of financial results for the
third quarter ended September 30, 2003. The company will release
results before the market opens on Thursday, October 30, 2003. John R.
Plachetka, Pharm.D., POZEN's chairman, president and chief executive
officer, and Matthew E. Czajkowski, chief financial officer, will host
the conference call the same day at 11:00 a.m. Eastern Time.
The conference call will be simulcast live on the Internet, and
can be accessed by logging on to www.pozen.com. A replay will be
available for seven days in the Investor Relations section of the
company's website. POZEN's third quarter results release can be
accessed in the News section of www.pozen.com and by clicking on the
release dated October 30, 2003.
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Product development efforts
are focused on diseases with unmet medical needs where POZEN can
improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has developed the largest and most advanced product
pipeline in the field of migraine. POZEN has development and
commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and
Nycomed. The company's common stock is traded on The Nasdaq Stock
Market under the symbol "POZN". For detailed company information,
including copies of this and other press releases, see POZEN's
Chief Financial Officer
Director, Investor Relations